Cargando…

Precise diagnosis and treatment of non-muscle invasive bladder cancer - A clinical perspective

According to the guidelines, transurethral resection of bladder tumor (TURBT) followed by intravesical therapy remains the standard strategy for the management of non-muscle invasive bladder cancer (NMIBC). However, even if patients receive standard strategy, the risk of postoperative recurrence and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yongjun, Wang, Chen, Li, Zonglin, Lu, Qiang, Li, Yuanwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927396/ https://www.ncbi.nlm.nih.gov/pubmed/36798814 http://dx.doi.org/10.3389/fonc.2023.1042552

Ejemplares similares

A large ectopic hepatocellular carcinoma with adrenal infiltration: a rare case report
por: Yang, Yongjun, et al.
Publicado: (2023)

Bacillus Calmette–Guérin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer
por: Su, Fei, et al.
Publicado: (2022)

Classification of Muscle-Invasive Bladder Cancer Based on Immunogenomic Profiling
por: Zhou, Xianghong, et al.
Publicado: (2020)

Metabolomics of Non-muscle Invasive Bladder Cancer: Biomarkers for Early Detection of Bladder Cancer
por: Cheng, Xiangming, et al.
Publicado: (2018)

Non-muscle invasive bladder cancer biomarkers beyond morphology
por: De Carlo, Camilla, et al.
Publicado: (2022)

Global research trends in non-muscle invasive bladder cancer: Bibliometric and visualized analysis
por: Deng, Sheng, et al.
Publicado: (2022)

Thermal Intravesical Chemotherapy Reduce Recurrence Rate for Non-muscle Invasive Bladder Cancer Patients: A Meta-Analysis
por: Liu, Kang, et al.
Publicado: (2020)

An MRI-based radiomics nomogram in predicting histologic grade of non-muscle-invasive bladder cancer
por: Li, Longchao, et al.
Publicado: (2023)

Knowledge of and Compliance With Guidelines in the Management of Non-Muscle-Invasive Bladder Cancer: A Survey of Chinese Urologists
por: Wang, Dan-Qi, et al.
Publicado: (2021)

Circulating Tumor DNA Analyses Predict Disease Recurrence in Non-Muscle-Invasive Bladder Cancer
por: Zhang, Jinghua, et al.
Publicado: (2021)

Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: From the Beginning to the Latest Developments
por: Roviello, Giandomenico, et al.
Publicado: (2022)

Modifying the Non-muscle Invasive Bladder Cancer Immune Microenvironment for Optimal Therapeutic Response
por: Annels, Nicola E., et al.
Publicado: (2020)

Efficacy and safety of photodynamic therapy for non–muscle-invasive bladder cancer: a systematic review and meta-analysis
por: Li, Haitao, et al.
Publicado: (2023)

Muscle-invasive angiosarcoma of the urinary bladder: Case report
por: Madiraju, Srigita, et al.
Publicado: (2023)

Urethral fistula and perineal collection during intravesical treatment for non-muscle invasive bladder cancer – A rare complication
por: Ong, Katherine, et al.
Publicado: (2022)

Serum metabolites as early detection markers of non-muscle invasive bladder cancer in Chinese patients
por: Zhao, Yi, et al.
Publicado: (2023)

Exosome-Derived Long Non-Coding RNAs as Non-Invasive Biomarkers of Bladder Cancer
por: Su, Quanxin, et al.
Publicado: (2021)

Intravesical Gemcitabine versus Intravesical Bacillus Calmette–Guérin for the Treatment of Non-Muscle Invasive Bladder Cancer: An Evaluation of Efficacy and Toxicity
por: Prasanna, Thiru, et al.
Publicado: (2017)

Association Between Antibiotic Treatment and the Efficacy of Intravesical BCG Therapy in Patients With High-Risk Non-Muscle Invasive Bladder Cancer
por: Pak, Sahyun, et al.
Publicado: (2021)

Muscle-invasive bladder cancer following radiotherapy for prostate adenocarcinoma
por: Barnett, Jack, et al.
Publicado: (2020)

Impact of the time of surgical delay on survival in patients with muscle-invasive bladder cancer
por: Li, Shuaishuai, et al.
Publicado: (2022)

Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs
por: Grabe-Heyne, Kristin, et al.
Publicado: (2023)

The Role of 18F-FDG PET/CT in Guiding Precision Medicine for Invasive Bladder Carcinoma
por: Girard, Antoine, et al.
Publicado: (2020)

Body composition as a predictor of oncological outcome in patients with non-muscle-invasive bladder cancer receiving intravesical instillation after transurethral resection of bladder tumor
por: Huang, Liang-Kang, et al.
Publicado: (2023)

Application of intra-arterial chemotherapy in high-risk non-muscle invasive bladder cancer: a systematic review and meta-analysis
por: You, Chengyu, et al.
Publicado: (2021)

SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016)
por: Lázaro, M., et al.
Publicado: (2016)

SEOM clinical guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2018)
por: González del Alba, A., et al.
Publicado: (2018)

Cost‐effectiveness of surveillance schedules in older adults with non‐muscle‐invasive bladder cancer
por: Heijnsdijk, Eveline A.M., et al.
Publicado: (2018)

The relationship between inflammatory response markers and the prognosis of non-muscle invasive bladder cancer and the development of a nomogram model
por: Yi, Xinping, et al.
Publicado: (2023)

Disease Management of Clinical Complete Responders to Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer: A Review of Literature
por: Wu, Jie, et al.
Publicado: (2022)

Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Non-muscle Invasive Bladder Cancer Patients: Initial Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Setting
por: Yuk, Hyeong Dong, et al.
Publicado: (2019)

Current Perspectives on Immunotherapy in the Peri-Operative Setting of Muscle-Infiltrating Bladder Cancer
por: Zucali, Paolo Andrea, et al.
Publicado: (2020)

AB007. Bladder-sparing treatments for muscle-invasive bladder cancer
por: Li, Shengwen, et al.
Publicado: (2017)

Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma
por: Shi, Wei-Wei, et al.
Publicado: (2022)

Peripheral tuberculin purified protein derivative specific T cell immunoreactivity dynamics in non-muscle invasive bladder cancer patients receiving bacillus Calmette-Guerin instillation treatment
por: Duan, Huangqi, et al.
Publicado: (2022)

Diagnostic performance of image technique based transurethral resection for non-muscle invasive bladder cancer: systematic review and diagnostic meta-analysis
por: Chen, Changhao, et al.
Publicado: (2019)

Development of a Prospective Data Registry System for Non-muscle-Invasive Bladder Cancer Patients Incorporated in the Electronic Patient File System
por: Akand, Murat, et al.
Publicado: (2019)

Modified immunoscore improves the prediction of progression-free survival in patients with non-muscle-invasive bladder cancer: A digital pathology study
por: Bieri, Uwe, et al.
Publicado: (2022)

Cancer-Specific Survival of Patients with Non-Muscle-Invasive Bladder Cancer: A Population-Based Analysis
por: Ślusarczyk, Aleksander, et al.
Publicado: (2023)

Radical cystectomy (bladder removal) against intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer (BRAVO): a protocol for a randomised controlled feasibility study
por: Oughton, Jamie B, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pnl82im5bh0kndv9dsqbmq5l9n